Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α ; volume:17 ; number:1 ; day:11 ; month:1 ; year:2019 ; pages:1-10 ; date:12.2019
Journal of translational medicine ; 17, Heft 1 (11.1.2019), 1-10, 12.2019
- Creator
-
Maida, Immacolata
Zanna, Paola
Guida, Stefania
Ferretta, Anna
Cocco, Tiziana
Palese, Luigi Leonardo
Londei, Paola
Benelli, Dario
Azzariti, Amalia
Tommasi, Stefania
Guida, Michele
Pellacani, Giovanni
Guida, Gabriella
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-019-1772-z
- URN
-
urn:nbn:de:101:1-2019021422365997150584
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maida, Immacolata
- Zanna, Paola
- Guida, Stefania
- Ferretta, Anna
- Cocco, Tiziana
- Palese, Luigi Leonardo
- Londei, Paola
- Benelli, Dario
- Azzariti, Amalia
- Tommasi, Stefania
- Guida, Michele
- Pellacani, Giovanni
- Guida, Gabriella
- SpringerLink (Online service)
Other Objects (12)
Clinical protein science in translational medicine targeting malignant melanoma
Popliteal lymph node dissection for metastases of cutaneous malignant melanoma
Cutaneous Malignant Melanoma and Targeted Therapy Based on the Biomarkers
Identification and characterization of cancer stem cells in cutaneous malignant melanoma
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Identification and characterization of cancer stem cells in cutaneous malignant melanoma
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective
Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma
Dormancy of cutaneous melanoma
Cutaneous melanoma in older patients
Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis
Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial
Clinical protein science in translational medicine targeting malignant melanoma
Popliteal lymph node dissection for metastases of cutaneous malignant melanoma
Cutaneous Malignant Melanoma and Targeted Therapy Based on the Biomarkers
Identification and characterization of cancer stem cells in cutaneous malignant melanoma
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Identification and characterization of cancer stem cells in cutaneous malignant melanoma
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective
Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma
Dormancy of cutaneous melanoma
Cutaneous melanoma in older patients
Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis
Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial
Clinical protein science in translational medicine targeting malignant melanoma
Popliteal lymph node dissection for metastases of cutaneous malignant melanoma
Cutaneous Malignant Melanoma and Targeted Therapy Based on the Biomarkers
Identification and characterization of cancer stem cells in cutaneous malignant melanoma
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Identification and characterization of cancer stem cells in cutaneous malignant melanoma
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective
Matrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma
Dormancy of cutaneous melanoma
Cutaneous melanoma in older patients
Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis